FINAL_LOGO-02.jpg
FOX Business Features Opinion Article Authored by AXIM Biotechnologies, Inc. CEO on Why Legal CBD is Good for Consumers and the Economy
June 05, 2019 09:00 ET | AXIM BIOTECHNOLOGIES, INC
NEW YORK, June 05, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today...
FINAL_LOGO-02.jpg
AXIM® Biotechnologies, Inc. Signs Cannabinoid Product Supply Agreement with Healthcare Company for Clinical Trials on Treatment of Periodontitis
June 03, 2019 09:00 ET | AXIM BIOTECHNOLOGIES, INC
NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today...
FINAL_LOGO-02.jpg
AXIM® Biotechnologies Announces Additional Purchase Order for Nutraceutical Product With Leading Direct Selling Company
May 15, 2019 15:29 ET | AXIM BIOTECHNOLOGIES, INC
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech”, “AXIM”, or the “Company”), a world leader in cannabinoid research and development, today...
FINAL_LOGO-02.jpg
AXIM® Biotechnologies to Present at Cannastocks 2019 Q1 Conference
May 14, 2019 09:00 ET | AXIM BIOTECHNOLOGIES, INC
NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech”, “Axim”, or the “Company”), a world leader in cannabinoid research and development, today...
FINAL_LOGO-02.jpg
AXIM® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms
May 09, 2019 09:00 ET | AXIM BIOTECHNOLOGIES, INC
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today announced...
New U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum Products
November 16, 2016 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, Nov. 16, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in hemp cannabinoid research and development, today announced that the United...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotechnologies, Inc. CEO to Speak on Emerging Markets and Cannabis Drug Market at Money Show Dallas
October 19, 2016 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, Oct. 19, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that its Chief Executive...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotechnologies, Inc. CEO to Speak at First-Ever National Symposium on Medical Cannabis for Healthcare Professionals in Mexico City
October 06, 2016 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, Oct. 06, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that its Chief Executive...
Axim-Sapphire_Logo_-04 (1).png
AXIM® Biotech Signs Exclusive Distribution Agreement With Israel’s Rafa Pharmaceuticals
September 19, 2016 09:00 ET | AXIM Biotechnologies, Inc
RAFA to Distribute Axim’s Award-Winning Cannabinoid Chewing Gum CanChew®NEW YORK, Sept. 19, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM), an innovative biotechnology company...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech CEO Appointed to American Pain Association Board of Advisors, Addresses American Opioid Abuse Epidemic
March 31, 2016 09:00 ET | AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 31, 2016 (GLOBE NEWSWIRE) -- Dr. George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM® Biotechnologies, Inc. (OTC:AXIM) was recently appointed to the American Pain...